Abstract
The amount of lipopolysaccharide (LPS) O antigen (OAg) and its chain length distribution are important factors that protect bacteria from serum complement. Salmonella enterica serovar Typhi produces LPS with long chain length distribution (L-OAg) controlled by the wzz gene, whereas serovar Typhimurium produces LPS with two OAg chain lengths: an L-OAg controlled by WzzST and a very long (VL) OAg determined by WzzfepE. This study shows that serovar Enteritidis also has a bimodal OAg distribution with two preferred OAg chain lengths similar to serovar Typhimurium. It was reported previously that OAg production by S. Typhi increases at the late exponential and stationary phases of growth. The results of this study demonstrate that increased amounts of L-OAg produced by S. Typhi grown to stationary phase confer higher levels of bacterial resistance to human serum. Production of OAg by serovars Typhimurium and Enteritidis was also under growth-phase-dependent regulation; however, while the total amount of OAg increased during growth, the VL-OAg distribution remained constant. The VL-OAg distribution was primarily responsible for complement resistance, protecting the non-typhoidal serovars from the lytic action of serum irrespective of the growth phase. As a result, the non-typhoidal species were significantly more resistant than S. Typhi to human serum. When S. Typhi was transformed with a multicopy plasmid containing the S. Typhimurium wzzfepE gene, resistance to serum increased to levels comparable to the non-typhoidal serovars. In contrast to the relevant role for high-molecular-mass OAg molecules, the presence of Vi antigen did not contribute to serum resistance of clinical isolates of serovar Typhi.
The number of O units that are attached to the lipid A-core is regulated by the chain length determinant Wzz (Rol, Cld) in an as yet unknown manner. Salmonella enterica serovar Typhi has a preferred chain length of about 16–35 repeats that is controlled by the wzz gene located downstream of the wba locus (Parkhill et al., 2001). In contrast, Salmonella Typhimurium possesses two functional wzz genes, resulting in a bimodal O-antigen length distribution: a long LPS (L-OAg) with 16–35 O-antigen units and a very long LPS (VL-OAg) estimated to contain more than 100 repeat units. The L-modal OAg length is determined by the Wzz protein encoded by the wzzST gene located adjacent to the wba locus, and the VL-OAg is controlled by the wzzfepE gene, a homologue of Escherichia coli fepE (Bastin et al., 1993; Batchelor et al., 1992; McClelland et al., 2001; Morona et al., 2003; Murray et al., 2003). On the other hand, two preferred lengths have been described in smooth isolates of Salmonella Enteritidis: a high-molecular-mass LPS, which has more than 11 OAg units, and a low-molecular-mass LPS that has an average OAg length of 5 units (Guard-Petter, 1998; Rahman et al., 1997).
It has been reported that the proper distribution of OAg chain lengths is required for complement resistance in species of Salmonella (Grossman et al., 1987; Hoare et al., 2006; Murray et al., 2003, 2005, 2006). However, not much is known about environmental regulation of OAg modal distribution and its effect on serum resistance. An early study indicated that Salmonella anatum OAg size and distribution are affected by the growth temperature (McConnell & Wright, 1979). More recently, Murray et al. (2005) reported that incubation of S. Typhimurium in heat-inactivated guinea pig serum induced the production of VL-OAg by S. Typhimurium, conferring a higher level of survival in serum. The same effect was observed when bacteria were grown under iron-limiting conditions; however, a wzzfepE-lacZ transcriptional fusion failed to show a significant change in expression under this growth condition. Thus, these reports did not determine the mechanisms responsible for the observed changes in LPS production. More recently, it has been demonstrated that expression of the S. Typhimurium OAg chain length determinant wzzST is induced in low Mg2+ plus Fe3+ medium, in a pathway that requires the PhoP/PhoQ and PmrA/PmrB two-component systems (Delgado et al., 2006).
Previous work from our laboratory demonstrated that production of OAg by S. Typhi Ty2 is regulated during bacterial growth, increasing at the late exponential and stationary phases. Increased amounts of OAg produced during stationary phase correlated with an increase in expression of the transcription elongation factor RfaH, which allows complete transcription of the wba operon (Bittner et al., 2002; Rojas et al., 2001). In this study, we show that OAg production by S. Typhimurium and S. Enteritidis is also growth-regulated; however, while the L-OAg modal distribution increases during growth, the amount of VL-OAg molecules remains relatively constant. Growth-regulation of L-OAg influences serum resistance of S. Typhi, conferring higher levels of protection to bacteria grown to stationary phase. The presence of VL-OAg in the non-typhoidal serovars protects bacteria from the lytic action of serum complement, irrespective of the growth phase. Expression of VL-OAg by S. Typhi increases serum resistance to levels comparable to those of the non-typhoidal serovars. In contrast, the Vi capsule does not contribute further to resistance to serum complement.
Bacterial strains, plasmids, media and growth conditions. Table 1 summarizes the properties of the bacterial strains and plasmids used in this study. Bacteria were grown aerobically at 37 °C in Luria–Bertani medium (LB) to exponential (OD600 0.1) or stationary (OD600 1.8–2) phase. Growth curves and details of growth conditions are shown in Supplementary Fig. S1, available with the online version of this paper. Where appropriate, media were supplemented with ampicillin (100 µg ml–1) or kanamycin (50 µg ml–1).Table 1. Bacterial strains and plasmids used in this study
Mutagenesis of wzz and tviC genes. Mutagenesis was performed by the method described by Datsenko & Wanner (2000) to construct chromosomal deletions by homologous recombination using PCR products. To disrupt tviC, which encodes UDP-GlcN-AcA 4-epimerase that is involved in Vi capsule synthesis, from S. Typhi and the chain-length determinant genes from S. Typhi Ty2 (wzz), S. Typhimurium LT2 (wzzST and wzzfepE) and S. Enteritidis PT4 (wzzSE and wzzfepE), cells were first transformed with the thermosensitive plasmid pKD46, which expresses the λ Red recombinase system, and subsequently transformed with PCR products that were generated using pKD4 , which contains an FRT-flanked kanamycin resistance gene (aph), as a template. Each primer pair also carried 30 bases that were homologous to the edge of the gene targeted for disruption. The sequences of the oligonucleotide primers used in this study are shown in Supplementary Table S1. In the presence of the Red recombinase system, the integration of the amplicons resulted in the targeted replacement of the wild-type gene by the antibiotic resistance cassette. The KanR transformants were replica plated in the absence of selective antibiotics at 42 °C, and finally assayed for ampicillin sensitivity to confirm the loss of pKD46. To obtain non-polar deletion mutants, the antibiotic resistance gene was removed by transforming the gene replacement mutants with pCP20, which encodes the FLP recombinase (Cherepanov & Wackernagel, 1995). Transformants were plated on LB agar plates containing ampicillin and kanamycin at 30 °C. Individual colonies were replica plated on LB agar plates, on LB agar plates containing ampicillin and on LB agar plates containing kanamycin and incubated at 42 °C. Transformants that had lost the resistance gene (aph) and plasmid pCP20 were selected as those colonies that were able to grow only on LB agar plates. Correct insertional gene replacements and the deletion of the antibiotic gene cassette were confirmed by PCR analysis.
LPS analysis. Culture samples obtained at different times during growth were adjusted to an OD600 2.0 in a final volume of 1.5 ml LB. Cells were centrifuged and the pellets were suspended in 150 µl of lysis buffer containing proteinase K, followed by hot phenol extraction and a subsequent extraction of the aqueous phase with diethylether. LPS was separated on 12 % (w/v) acrylamide gels using a Tricine-SDS buffer system and visualized by silver staining (Marolda et al., 2006). Densitometry analysis was performed using the UN-SCANT-IT gel software (Silk Scientific). To perform this analysis, LPS samples were separated on 12 % (w/v) acrylamide gels using a Tricine-SDS buffer system (Marolda et al., 2006) to visualize the unsubstituted lipid A-core region. The ratio of the relative intensity of the lipid A-core band to the average intensity of the bands corresponding to total OAg and VL-OAg was calculated by quantifying the pixels in a narrow window across the centre of each lane. The densitometric analysis was calibrated by determining the ratio of the relative intensity of the lipid A-core region relative to the average intensity of the OAg bands using a range of loading volumes of LPS samples. As shown in Supplementary Fig. S2, the total pixels increased linearly with respect to the volume loaded, indicating that there is no saturation of bands in the range of loading volumes (from 1–4 µl) used. Representative densitograms are shown in Supplementary Fig. S3.
Western blot analyses were performed as described by Marolda et al. (2006). Briefly, LPS was transferred to a PVDF membrane for 75 min at 250 mA and blocked for 90 min in 5 % (w/v) skim milk at room temperature. The membrane was incubated overnight with a polyclonal rabbit antiserum against Salmonella group D1 or group B (Probac do Brasil, Produtos Bacteriológicos) as a primary antibody, and horseradish peroxidase-conjugated, goat anti-rabbit (Pierce) as a secondary antibody. Detection was performed using the SuperSignal West Pico chemiluminiscent substrate (Pierce).
Serum resistance. Human serum samples obtained from healthy donors (provided by the blood bank of the Clinical Hospital from the University of Chile) devoid of antibodies against Salmonella group D1 and Salmonella group B, were pooled, divided into small aliquots and stored at –70 °C until use. Bacteria were grown in LB medium to exponential or stationary phase (OD600 0.1 and 1.8–2, respectively). Culture samples were diluted in LB medium to 103 c.f.u. ml–1 and 20 µl was mixed with 20 µl serum, diluted in LB to 0, 2.5, 5, 10, 20 and 40 % final concentration. After 20 min incubation at 37 °C, complement function was stopped by the addition of 60 µl cold LB medium. Tubes were kept on ice until the full contents of each tube were plated onto LB agar plates to determine viable bacterial numbers. Resistance to serum was calculated as percentage survival, taking as 100 % the bacterial counts obtained after incubation in LB (0 % serum). Each experiment was carried out in duplicate in at least three independent assays. Data are expressed as means±SE.
Growth-phase-dependent regulation of O-antigen synthesis in Salmonella serovarsPrevious work from our laboratory demonstrated that the production of OAg by S. Typhi increases at the onset of stationary phase and correlates with a growth-regulated expression of the transcription elongation factor RfaH (Bittner et al., 2002; Rojas et al., 2001). To investigate whether LPS production is subject to growth-phase regulation in the non-typhoid serovars Typhimurium and Enteritidis, we analysed the LPS profiles in silver-stained polyacrylamide gels of bacterial cells collected at different stages of growth. Gel loadings were normalized by the bacterial density at the starting point of the LPS preparations, as described in Methods. In accordance with our previous results (Bittner et al., 2002; Rojas et al., 2001), the amount of OAg produced by serovar Typhi increased throughout the bacterial growth cycle (Fig. 1a, left panel, lanes 1–4). The densitometric quantification of the lanes in the gel (Fig. 1a, right panel) showed a significant increase in the ratio of OAg to lipid A-core region in the sample grown to stationary phase (OD600 1.8) compared to the sample grown to exponential phase (OD600 0.1). In S. Typhimurium LT2 (Fig. 1b, left panel, lanes 1–4) growth-phase-dependent regulation of OAg synthesis was also observed; however, while the amount of low-molecular-mass OAg molecules and of the L-OAg modal distribution increased during growth, the amount of VL-OAg chains remained relatively constant. Examination of LPS production by S. Enteritidis PT4 (Fig. 1c, left panel, lanes 1–4) revealed the presence of high-molecular-mass OAg molecules, similar to the VL-OAg distribution of serovar Typhimurium. To our knowledge, this modal length has not been described previously in serovar Enteritidis, so we confirmed that these bands contained LPS OAg by Western blotting using an anti-group D1-specific antibody (Fig. 1c, left panel, lane 5). Western blots were also performed using anti-group D1-specific and anti-group B-specific antibodies for detecting LPS OAg from serovar Typhi (Fig. 1a, left panel, lane 5) and serovar Typhimurium (Fig. 1b, left panel, lane 5), respectively. A differential growth-phase-regulation of OAg synthesis was observed in S. Enteritidis, similar to serovar Typhimurium. This was confirmed by densitometric quantification of the lanes in the gels. In both serovars, the amount of total OAg relative to the lipid A-core region increased significantly during growth, yet no significant differences in the ratio of VL-OAg to lipid A-core were observed (Fig. 1b, c, right panels).
|
At the moment, we can only speculate how environmental conditions could differentially modulate the OAg modal distribution; however, several reports have begun to unravel a variety of mechanisms involved in OAg chain length regulation. It has been shown in S. Typhimurium that while wzzST expression is regulated in response to conditions of low Mg2+ plus Fe3+ through the PmrA/PmrB and RcsC/YojN/RcsB systems (Delgado et al., 2006), wzzfepE expression is regulated by conditions that stimulate swarming motility (Wang et al., 2004). Additional control of wzzfepE expression by the flagellar master regulator FlhDC has been reported in E. coli (Stafford et al., 2005). In addition, genome-wide analysis of the DNA adenine methyltransferase (Dam) regulon in E. coli described wzzB as one of many genes found to be repressed by the presence of this regulator (Robbins-Manke et al., 2005). Since Dam levels are downregulated in stationary phase (Seshasayee, 2007), the increase of wzzB transcription could be a result of diminished levels of Dam.
In a previous study, we demonstrated a differential growth-phase regulation of OAg production in Shigella flexneri 2a (Carter et al., 2007). We showed that, while VL-OAg increased significantly during growth, the short LPS (S-OAg) distribution remained relatively constant. VL-OAg production correlated with growth-dependent regulation of the rfaH gene. Our results also indicated that RfaH is essential for expression of the wzy polymerase gene, but not for wzzB or wzzpHS-2, suggesting that the cellular levels of Wzy are critical for VL-OAg production and normal OAg chain-length distribution in Shigella flexneri 2a. In Salmonella, the wzy gene is a single transcriptional unit and thus it is probably not regulated by RfaH. Therefore, at present we do not have any insights about the mechanisms of differential growth-phase regulation of OAg modal distribution in serovars of Salmonella.
Effect of growth-dependent regulation of O-antigen on serum resistance
As described above, the wild-type LT2 strain grown to stationary phase expressed higher amounts of low-molecular-mass OAg molecules and of L-OAg than bacteria grown to exponential phase, whereas VL-OAg levels remained relatively constant (Fig. 2a, lanes 1 and 2). Similar growth-phase regulation of LPS production was observed in the virulent S. Typhimurium SL1344 strain (Fig. 2a, lanes 3 and 4), suggesting that differential regulation of OAg is not restricted to a particular strain, but rather is most likely a property of this serovar. Additionally, we studied the effect of growth phase on LPS production by deletion mutants in the wzzST and wzzfepE genes. The LT2 ΔwzzST mutant (strain MTM4) did not produce the L-OAg distribution but expressed higher amounts of random-length OAg when grown to stationary phase, compared to exponential phase. This mutant produced VL-OAg chains similar to the wild-type (Fig. 2a, lanes 5 and 6). On the other hand, the LT2 ΔwzzfepE mutant (strain MTM113) was devoid of VL-OAg while L-OAg distribution and the production of low-molecular-mass molecules was growth-phase-regulated, as in the wild-type LT2 strain (Fig. 2a, lanes 7 and 8). The S. Enteritidis wild-type PT4 and Di62 strains and the PT4 isogenic ΔwzzSE (MSE4) and ΔwzzfepE (strain MSE113) mutants showed LPS patterns (Fig. 3a) that were similar to those of S. Typhimurium. Thus, differential regulation of OAg modal distribution appears to be a property common to both these Salmonella serovars.
|
|
To ascertain whether growth-phase regulation of LPS production influences resistance to the killing effect of human serum, bacteria grown to exponential or stationary phase were added to different concentrations of serum and assayed for serum resistance as described in Methods. The results showed that the wild-type S. Typhimurium LT2 and its isogenic ΔwzzST mutant (strain MTM4) were quite resistant to the lytic action of complement, showing over 70 % survival after 20 min of incubation in 20 % serum, irrespective of the growth phase (Fig. 2b). In contrast, S. Typhimurium MTM113 (ΔwzzfepE) was very sensitive to serum killing, particularly when grown to exponential phase; no survivors were recovered after 20 min of incubation in 20 % serum compared to approximately 30 % survival of bacteria grown to stationary phase (Fig. 2b). The virulent strain SL1344 was highly resistant to the lytic action of complement when grown to stationary phase, similar to LT2 (Fig. 2b, left panel). Bacteria grown to exponential phase were significantly more sensitive; nevertheless, over 50 % survival after 20 min incubation in 20 % serum was obtained (Fig. 2b, left panel). These results indicate that, although small differences may occur among different strains, serovar Typhimurium is quite resistant to human serum irrespective of differences in virulence.
Our results demonstrate the importance of VL-OAg molecules in protection of S. Typhimurium from the bactericidal action of human complement. They also indicate that the growth-regulated amount of L-OAg is relevant to serum resistance when VL-OAg distribution is absent. Our data are in contrast to findings by Murray et al. (2005) indicating that the wzzST gene is primarily responsible for serum resistance of serovar Typhimurium strain C5, whereas wzzfepE provides little serum resistance alone. These authors reported an important role for the VL-OAg distribution either when it was induced by environmental conditions such as incubation in serum or under iron limitation, or when the wzzfepE was overexpressed. In this study we clearly show that the VL-OAg distribution produced by aerobically grown bacteria in LB confers serum resistance to serovar Typhimurium at both exponential and stationary phases of growth. The amount of L-OAg further contributes to resistance to human serum. The differences between our results and those of Murray et al. (2005) could be due to differences in growth conditions or strains used in the two studies and/or to the use of guinea pig serum instead of human serum in the study by Murray et al. (2005).
Similar to S. Typhimurium, the wild-type PT4 and Di62 strains of S. Enteritidis were highly resistant to complement; approximately 70 % survival was obtained after 20 min incubation in 20 % serum, irrespective of the growth phase (Fig. 3b, left panel). However, the relative impact of the two wzz genes of serovar Enteritidis on serum resistance was different from that in S. Typhimurium LT2. Deletion of the PT4 wzzSE gene caused a considerable reduction in the ability to resist the lytic action of serum at both exponential and stationary phases (Fig. 3b, right panel). On the other hand, the ΔwzzfepE mutant (strain MSE113) was as resistant as the wild-type when grown to stationary phase, but it was highly sensitive when grown to exponential phase (Fig. 3b, right panel). These results indicate that the amount of L-OAg is crucial for survival of S. Enteritidis while the VL-OAg modal distribution contributes to serum resistance when a small amount of L-OAg is produced.
Expression of VL-OAg increases serum resistance of S. Typhi
To confirm the significance of high-molecular mass OAg in resistance of Salmonella to complement-mediated killing, we transformed S. Typhi Ty2 and its isogenic Δwzz mutant with the S. Typhimurium wzzfepE gene cloned in pGEM-T (pJC142). In S. Typhi wzzfepE is a pseudogene (Deng et al., 2003) and thus this serovar cannot synthesize VL-OAg (Fig. 4a, lanes 1 and 2). The complemented Ty2/pJC142 strain produced VL-OAg as in S. Typhimurium, whereas expression of L-OAg was similar to that of the wild-type Ty2 strain (Fig. 4a, lanes 3 and 4). The Δwzz mutant (M985) showed a random distribution of OAg lengths (Fig. 4a, lanes 5 and 6), while the complemented M985/pJC142 strain showed a similar LPS profile but expressed VL-OAg (Fig. 4a, lanes 7 and 8). Higher amounts of OAg were produced at the stationary phase of growth.
|
The effect of growth-phase regulation of OAg on serum resistance is shown in Fig. 4(b). S. Typhi Ty2 grown to exponential phase was highly susceptible to the bactericidal action of serum; no survivors were recovered after 20 min incubation in 10 % serum. In contrast, stationary-phase-grown bacteria showed approximately 60 % survival under the same conditions, indicating that a higher density of OAg molecules confers a better level of protection against lysis by complement. The S. Typhi Δwzz mutant was completely killed by serum irrespective of the growth stage (Fig. 4b, right panel), indicating that OAg with a proper distribution of chain lengths is required for serum resistance. As a result of this, in S. Typhi which is naturally devoid of VL-OAg, the presence and the amount of L-OAg are crucial for survival in serum. Expression of VL-OAg by Ty2/pJC142 increased serum resistance to levels comparable to those of the non-typhoidal serovars under both growth conditions (Fig. 4b, compare with Figs 2b and 3b). A different result was obtained in M985/pJC142. As shown in Fig. 4(c), the presence of VL-OAg protected the bacteria from complement, but a growth-phase-dependent behaviour was still observed: bacteria grown to stationary phase were completely resistant in up to 40 % serum, while bacteria grown to exponential phase showed only 10 % survival under this condition. This provides stronger evidence for the importance of the L-OAg distribution for serovar Typhi resistance to lysis by complement.
In summary, our data demonstrate that growth-regulation of OAg production and chain length distribution are central for complement resistance of Salmonella serovars, and underline the importance of controlling the bacterial stage of growth to assay serum sensitivity. Although other growth effects cannot be ruled out, our results strongly suggest that the regulation of OAg modal distribution is central for serum resistance. This notion is supported mainly by two observations: (i) serum resistance is growth-phase independent in non-typhoidal serovars expressing VL-OAg (Figs 2b and 3b), and (ii) serum resistance of S. Typhi Ty2 becomes growth-phase independent when complemented to produce VL-OAg (Fig. 4).
The S. Typhi Vi antigen does not contribute to serum resistance
Our results showing that serovar Typhi is more sensitive to the lytic action of human serum than the non-typhoidal serovars were unexpected considering that S. Typhi causes a systemic disease in its human host. Strain Ty2 does not express the Vi capsule due to the spontaneous loss of a portion of the pathogenicity island 7 (SPI7) that contains the viaB genes encoding the proteins for the biosynthesis and export of the Vi capsular antigen (Bueno et al., 2004). Considering previous reports indicating that the Vi capsule may enhance survival of S. Typhi in serum (Hashimoto et al., 1993; Looney & Steigbigel, 1986), we asked whether the presence of Vi antigen confers additional protection from complement-mediated lysis. To this end, we tested the sensitivity of Vi– and Vi+ clinical isolates of S. Typhi to serum (CC737 and CC761, respectively). Both strains were characterized by an agglutination assay with Vi-specific antisera. The clinical isolates showed LPS profiles (Fig. 5a) and abilities to resist the lytic action of serum (Fig. 5b) similar to those of the Ty2 strain at both exponential and stationary phases of growth. These results suggested that the Vi antigen does not contribute to survival of S. Typhi in human serum. To confirm this notion, we constructed a Vi– mutant (CC761ΔtviC) from the clinical isolate CC761 by deletion of the tviC gene encoding UDP-GlcN-AcA 4-epimerase, involved in the synthesis of the Vi antigen (Hashimoto et al., 1993). Both strains showed growth phase regulation of LPS production and serum sensitivity similar to the other serovar Typhi strains (Fig. 5a, b).
|
Thus, our results do not agree with previous studies indicating that capsulated strains of S. Typhi exhibit increased serum resistance (Hashimoto et al., 1993; Looney & Steigbigel, 1986). Rather, they are in accordance with studies conducted in uropathogenic E. coli O75 : K5, which suggest that the capsular antigen plays a minor role in protecting bacteria from the bactericidal action of human serum (Burns & Hull, 1998).
The Vi capsular polysaccharide is thought to be expressed during infection, as indicated by protection against human typhoid fever following vaccination with the Vi antigen (Klugman et al., 1987) and by the observation that isolates from blood of patients almost always express the Vi antigen (Robbins & Robbins, 1984). Studies conducted recently to understand the pathogenesis of infection by S. Typhi have suggested new roles for the Vi antigen as a virulence factor. It has been demonstrated that expression of the viaB genes is induced during infection of human macrophages in vitro (Raffatellu et al., 2005), indicating a role of the Vi antigen during interaction of bacteria with host phagocytes. In addition, it has been suggested that the Vi capsule allows S. Typhi to downregulate a Toll-like-receptor-mediated host response in the intestinal mucosa that leads to neutrophil infiltration and consequently to evasion of innate immune recognition (Raffatellu et al., 2006). Thus, the Vi capsule may contribute to survival of serovar Typhi in human tissue or blood by a mechanism different from serum resistance.
Concluding remarks
Collectively, our results demonstrate that the LPS OAg is more important for survival in serum than the Vi antigen, and that regulation of OAg production and chain length distribution is crucial for protection of Salmonella from complement-mediated lysis. In addition, our data showing that non-typhoidal serovars are more resistant than serovar Typhi to human serum suggest that resistance to human serum does not contribute to host specificity or to pathogenesis of systemic disease by S. Typhi.
References
Batchelor, R. A., Alifano, P., Biffali, E., Hull, S. I. & Hull, R. A. (1992). Nucleotide sequences of the genes regulating O-polysaccharide antigen chain length (rol) from Escherichia coli and Salmonella typhimurium: protein homology and functional complementation. J Bacteriol 174, 5228–5236.
Bengoechea, J. A., Najdenski, H. & Skurnik, M. (2004). Lipopolysaccharide O antigen status of Yersinia enterocolitica O : 8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors. Mol Microbiol 52, 451–469.[CrossRef][Medline]
Bittner, M., Saldias, S., Estevez, C., Zaldivar, M., Marolda, C. L., Valvano, M. A. & Contreras, I. (2002). O-antigen expression in Salmonella enterica serovar Typhi is regulated by nitrogen availability through RpoN-mediated transcriptional control of the rfaH gene. Microbiology 148, 3789–3799.
Bueno, S. M., Santiviago, C. A., Murillo, A. A., Fuentes, J. A., Trombert, A. N., Rodas, P. I., Youderian, P. & Mora, G. C. (2004). Precise excision of the large pathogenicity island, SPI7, in Salmonella enterica serovar Typhi. J Bacteriol 186, 3202–3213.
Burns, S. M. & Hull, S. I. (1998). Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75 : K5. Infect Immun 66, 4244–4253.
Carter, J. A., Blondel, C. J., Zaldívar, M., Álvarez, S. A., Marolda, C. L., Valvano, M. A. & Contreras, I. (2007). O-antigen modal chain length in Shigella flexneri 2a is growth-regulated through RfaH-mediated transcriptional control of the wzy gene. Microbiology 153, 3499–3507.
Cherepanov, P. P. & Wackernagel, W. (1995). Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158, 9–14.[CrossRef][Medline]
Clas, F. & Loos, M. (1981). Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota. Infect Immun 31, 1138–1144.
Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97, 6640–6645.
Delgado, M. A., Mouslim, C. & Groisman, E. A. (2006). The PmrA/PmrB and RcsC/YojN/RcsB systems control expression of the Salmonella O-antigen chain length determinant. Mol Microbiol 60, 39–50.[CrossRef][Medline]
Deng, W., Liou, S. R., Plunkett, G., III, Mayhew, G. F., Rose, D. J., Burland, V., Kodoyianni, V., Schwartz, D. C. & Blattner, F. R. (2003). Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol 185, 2330–2337.
Grossman, N., Schmetz, M. A., Foulds, J., Klima, E. N., Jimenez-Lucho, V. E., Leive, L. L. & Joiner, K. A. (1987). Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo. J Bacteriol 169, 856–863.
Guard-Petter, J. (1998). Variants of smooth Salmonella enterica serovar Enteritidis that grow to higher cell density than the wild type are more virulent. Appl Environ Microbiol 64, 2166–2172.
Hashimoto, Y., Li, N., Yokoyama, H. & Ezaki, T. (1993). Complete nucleotide sequence and molecular characterization of ViaB region encoding Vi antigen in Salmonella typhi. J Bacteriol 175, 4456–4465.
Hoare, A., Bittner, M., Carter, J., Alvarez, S., Zaldivar, M., Bravo, D., Valvano, M. A. & Contreras, I. (2006). The outer core lipopolysaccharide of Salmonella enterica serovar Typhi is required for bacterial entry into epithelial cells. Infect Immun 74, 1555–1564.
Hong, M. & Payne, S. M. (1997). Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol Microbiol 24, 779–791.[CrossRef][Medline]
Joiner, K. A. (1988). Complement evasion by bacteria and parasites. Annu Rev Microbiol 42, 201–230.[CrossRef][Medline]
Joiner, K. A., Grossman, N., Schmetz, M. & Leive, L. (1986). C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol 136, 710–715.[Abstract]
Klugman, K. P., Gilbertson, I. T., Koornhof, H. J., Robbins, J. B., Schneerson, R., Schulz, D., Cadoz, M. & Armand, J. (1987). Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 2, 1165–1169.[CrossRef][Medline]
Liang-Takasaki, C.-J., Saxén, H., Mäkelä, P. H. & Leive, L. (1983). Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of Salmonellae. Infect Immun 41, 563–569.
Looney, R. J. & Steigbigel, R. T. (1986). Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J Lab Clin Med 108, 506–516.[Medline]
Mäkelä, P. H., Hovi, M., Saxen, H., Valtonen, M. & Valtonen, V. (1988). Salmonella, complement and mouse macrophages. Immunol Lett 19, 217–222.[CrossRef][Medline]
Marolda, C. L., Lahiry, P., Vines, E., Saldias, S. & Valvano, M. A. (2006). Micromethods for the characterization of lipid A-core and O-antigen lipopolysaccharide. Methods Mol Biol 347, 237–252.[Medline]
McClelland, M., Sanderson, K. E., Spieth, J., Clifton, S. W., Latreille, P., Courtney, L., Porwollik, S., Ali, J., Dante, M. & other authors (2001). Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413, 852–856.[CrossRef][Medline]
McConnell, M. & Wright, A. (1979). Variation in the structure and bacteriophage-inactivating capacity of Salmonella anatum lipopolysaccharide as a function of growth temperature. J Bacteriol 137, 746–751.
Morona, R., Daniels, C. & Van Den Bosch, L. (2003). Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence. Microbiology 149, 925–939.
Murray, G. L., Attridge, S. R. & Morona, R. (2003). Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz. Mol Microbiol 47, 1395–1406.[CrossRef][Medline]
Murray, G. L., Attridge, S. R. & Morona, R. (2005). Inducible serum resistance in Salmonella typhimurium is dependent on wzz(fepE)-regulated very long O antigen chains. Microbes Infect 7, 1296–1304.[CrossRef][Medline]
Murray, G. L., Attridge, S. R. & Morona, R. (2006). Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar Typhimurium with macrophages and complement. J Bacteriol 188, 2735–2739.
Nevola, J. J., Stocker, B. A., Laux, D. C. & Cohen, P. S. (1985). Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective mutants. Infect Immun 50, 152–159.
Parkhill, J., Dougan, G., James, K. D., Thomson, N. R., Pickard, D., Wain, J., Churcher, C., Mungall, K. L., Bentley, S. D. & other authors (2001). Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413, 848–852.[CrossRef][Medline]
Raetz, C. R. & Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu Rev Biochem 71, 635–700.[CrossRef][Medline]
Raffatellu, M., Chessa, D., Wilson, R. P., Dusold, R., Rubino, S. & Baumler, A. J. (2005). The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun 73, 3367–3374.
Raffatellu, M., Chessa, D., Wilson, R. P., Tukel, C., Akcelik, M. & Baumler, A. J. (2006). Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun 74, 19–27.
Rahman, M. M., Guard-Petter, J. & Carlson, R. W. (1997). A virulent isolate of Salmonella enteritidis produces a Salmonella typhi-like lipopolysaccharide. J Bacteriol 179, 2126–2131.
Robbins, J. D. & Robbins, J. B. (1984). Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 150, 436–449.[Medline]
Robbins-Manke, J. L., Zdraveski, Z. Z., Marinus, M. & Essigmann, J. M. (2005). Analysis of global gene expression and double strand-break formation in DNA adenine methyltransferase- and mismatch repair-deficient Escherichia coli. J Bacteriol 187, 7027–7037.
Rojas, G., Saldias, S., Bittner, M., Zaldivar, M. & Contreras, I. (2001). The rfaH gene, which affects lipopolysaccharide synthesis in Salmonella enterica serovar Typhi, is differentially expressed during the bacterial growth phase. FEMS Microbiol Lett 204, 123–128.[CrossRef][Medline]
Saxén, H., Reima, I. & Mäkëla, P. H. (1987). Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse. Microb Pathog 2, 15–28.[CrossRef][Medline]
Seshasayee, A. S. (2007). An assessment of the role of DNA adenine methyltransferase on gene expression regulation in E. coli. PLoS ONE 2, e273[CrossRef]
Skurnik, M., Venho, R., Bengoechea, J. A. & Moriyon, I. (1999). The lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3 is required for virulence and plays a role in outer membrane integrity. Mol Microbiol 31, 1443–1462.[CrossRef][Medline]
Stafford, G. P., Ogi, T. & Hughes, C. (2005). Binding and transcriptional activation of non-flagellar genes by the Escherichia coli flagellar master regulator. Microbiology 151, 1779–1788.
Tomas, J. M., Benedi, V. J., Ciurana, B. & Jofre, J. (1986). Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 54, 85–89.
Wang, Q., Frye, J. G., McClelland, M. & Harshey, R. M. (2004). Gene expression patterns during swarming in Salmonella typhimurium: genes specific to surface growth and putative new motility and pathogenicity genes. Mol Microbiol 52, 169–187.[CrossRef][Medline]
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |